Oppenheimer & Co. Inc. lifted its position in shares of Synopsys, Inc. (NASDAQ:SNPS – Free Report) by 8.3% in the 3rd quarter, according to its most recent 13F filing with the SEC. The firm owned 24,339 shares of the semiconductor company’s stock after acquiring an additional 1,869 shares during the quarter. Oppenheimer & Co. Inc.’s holdings in Synopsys were worth $12,009,000 at the end of the most recent quarter.
A number of other hedge funds and other institutional investors have also added to or reduced their stakes in SNPS. Norges Bank purchased a new stake in shares of Synopsys during the 2nd quarter valued at approximately $647,964,000. Ameriprise Financial Inc. lifted its position in shares of Synopsys by 29.1% during the second quarter. Ameriprise Financial Inc. now owns 2,598,874 shares of the semiconductor company’s stock worth $1,333,095,000 after acquiring an additional 585,494 shares in the last quarter. Massachusetts Financial Services Co. MA lifted its position in shares of Synopsys by 177.5% during the third quarter. Massachusetts Financial Services Co. MA now owns 865,987 shares of the semiconductor company’s stock worth $427,269,000 after acquiring an additional 553,924 shares in the last quarter. Ninety One UK Ltd bought a new position in shares of Synopsys in the third quarter worth $249,851,000. Finally, Aspex Management HK Ltd grew its position in shares of Synopsys by 106.0% in the second quarter. Aspex Management HK Ltd now owns 645,895 shares of the semiconductor company’s stock valued at $331,137,000 after purchasing an additional 332,364 shares in the last quarter. 85.47% of the stock is currently owned by institutional investors.
Synopsys Price Performance
SNPS stock opened at $438.90 on Tuesday. The firm has a 50 day simple moving average of $479.34 and a two-hundred day simple moving average of $493.86. The stock has a market cap of $83.97 billion, a PE ratio of 54.93, a P/E/G ratio of 3.56 and a beta of 1.12. Synopsys, Inc. has a one year low of $365.74 and a one year high of $651.73. The company has a debt-to-equity ratio of 0.48, a current ratio of 1.62 and a quick ratio of 1.52.
Analysts Set New Price Targets
A number of analysts recently issued reports on the company. JPMorgan Chase & Co. increased their price objective on Synopsys from $600.00 to $650.00 and gave the stock an “overweight” rating in a report on Thursday, December 11th. KeyCorp upped their price target on Synopsys from $575.00 to $600.00 and gave the company an “overweight” rating in a research report on Thursday, December 11th. Bank of America raised shares of Synopsys from an “underperform” rating to a “neutral” rating and lowered their price target for the stock from $525.00 to $500.00 in a report on Monday, December 8th. Rosenblatt Securities raised shares of Synopsys from a “neutral” rating to a “buy” rating and reduced their price objective for the company from $605.00 to $560.00 in a research note on Tuesday, December 9th. Finally, Weiss Ratings reaffirmed a “hold (c)” rating on shares of Synopsys in a report on Thursday, January 22nd. Nine research analysts have rated the stock with a Buy rating, six have given a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat.com, Synopsys presently has a consensus rating of “Moderate Buy” and an average target price of $553.57.
Check Out Our Latest Research Report on Synopsys
Insider Transactions at Synopsys
In related news, insider Janet Lee sold 250 shares of the business’s stock in a transaction that occurred on Monday, January 12th. The stock was sold at an average price of $530.00, for a total value of $132,500.00. Following the completion of the sale, the insider owned 11,959 shares in the company, valued at $6,338,270. The trade was a 2.05% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Also, CFO Shelagh Glaser sold 3,657 shares of the stock in a transaction that occurred on Friday, December 19th. The shares were sold at an average price of $460.77, for a total transaction of $1,685,035.89. Following the transaction, the chief financial officer owned 17,842 shares in the company, valued at $8,221,058.34. The trade was a 17.01% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Over the last three months, insiders have sold 4,157 shares of company stock worth $1,945,036. 0.62% of the stock is currently owned by insiders.
Synopsys Company Profile
Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front‑end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape‑out.
In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.
Featured Stories
- Five stocks we like better than Synopsys
- The buying spree that no one is talking about
- How to collect $500-$800 weekly (BlackRock’s system)
- Trump’s AI Secret: 100X Faster Than Nvidia
- NEW LAW: Congress Approves Setup For Digital Dollar?
- They just tried to kill gold
Want to see what other hedge funds are holding SNPS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Synopsys, Inc. (NASDAQ:SNPS – Free Report).
Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.
